Akèy › Anplwayè › Unicon Pharma Inc › Clinical Trial Management II
Clinical Trial Management II nan Unicon Pharma Inc: Salè H-1B
5 aplikasyon kondisyon travay pou tit travay Clinical Trial Management II nan Unicon Pharma Inc. Salè baz medyàn ofri $97,739; mwatye mitan $97,614–$100,942.
Demann (LCA)5
Salè medyan ofri$97,739
Mwatye salè yo$97,614–$100,942
10yèm–90yèm pousantaj$97,614–$100,942
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 3 | $100,942 |
| FY2024 | 1 | $97,614 |
| FY2025 | 1 | $97,614 |
Aplikasyon
| Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|
| $97,739 Nivo II | Boston, MA | Nov 1, 2022 | Nov 1, 2022 | Certifye, apre retire |
| $97,614 Nivo II | Boston, MA | May 16, 2022 | May 23, 2022 | Certifye, apre retire |
| $100,942 Nivo II | Boston, MA | May 9, 2022 | Oct 1, 2022 | Certifye, apre retire |
| $97,614 Nivo II | Boston, MA | Apr 27, 2022 | May 16, 2022 | Certifye, apre retire |
| $100,942 Nivo II | Boston, MA | Aug 20, 2020 | Sep 14, 2020 | Certifye, apre retire |
Lòt travay nan Unicon Pharma Inc
- Validation Engineer$89,398
- Validation Analyst$89,398
- CQV Engineer$88,462
- Specialist Study Management$66,622
- Validation Specialist$87,422
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).